Results 1 to 10 of about 39,174 (210)
Development and Validation of a Rapid Screening Test for HTLV-I IgG Antibodies [PDF]
Initial diagnosis of human T cell lymphotropic virus (HTLV) infections is mainly based by detecting antibodies in plasma or serum using laboratory-based methods.
Bobby Brooke Herrera +2 more
doaj +2 more sources
A novel high-performance rapid screening test for the detection of total HTLV-I and HTLV-II antibodies in HTLV-I/II infected patients [PDF]
Rapid diagnosis of human T-cell lymphotropic virus (HTLV) type-I and -II infections are essential for timely and cost-effective disease interventions.
Lay Sin Teoh +6 more
doaj +2 more sources
Human T-cell lymphotropic virus type 1 and 2 (HTLV-1/2) screening is not mandatory in Spanish blood banks. In Catalonia, selective screening was introduced in 2008, followed by universal screening in 2011.
Maria Piron +8 more
doaj +1 more source
Understanding HTLV-I Protease [PDF]
AbstractHuman T cell leukemia virus type I (HTLV-I) is a human retrovirus that has been clinically associated with adult T cell leukemia/lymphoma, and it has been designated as a dangerous emerging pathogen by the Centers for Disease Control. Like other retroviruses, proteolytic processing of specific sites in polyprotein precursors by a retroviral ...
Shuker, Suzanne Beckham +3 more
openaire +2 more sources
Upregulation of Neuropilin-1 Inhibits HTLV-1 Infection
Infection with human T-cell leukemia virus type 1 (HTLV-1) can produce a spectrum of pathological effects ranging from inflammatory disorders to leukemia. In vivo, HTLV-1 predominantly infects CD4+ T-cells.
Wesley Kendle +5 more
doaj +1 more source
Human T-lymphotropic virus types I and II (HTLV-I and -II) cause myelopathy; HTLV-I, but not HTLV-II, causes adult T-cell leukemia. Whether HTLV-II is associated with other diseases is unknown.
Edward L. Murphy +10 more
doaj +1 more source
Human T cell leukemia virus type-I (HTLV-I) infection is associated with spontaneous T cell activation and uncontrolled lymphocyte proliferation. An exacerbated type-1 immune response with production of pro-inflammatory cytokines (interferon-gamma and ...
Silvane Braga Santos +4 more
doaj +1 more source
HTLV‐I Uveitis: A Distinct Clinical Entity Caused by HTLV‐I [PDF]
Seroepidemiological, clinical and virological studies were carried out in an HTLV‐I endemic area to find out if HTLV‐I caused an intraocular inflammatory disorder, uveitis. The seroprevalence in patients with uveitis without defined etiologies (62/175, 35.4%) was significantly higher than that in patients with non‐uveitic ocular diseases (42/261, 16.1%)
Mochizuki, Manabu +9 more
openaire +2 more sources
DETECTION OF HTLV-I ANTIBODIES AND DNA IN BLOOD SAMPLE OF A PATIENT WITH MYELOPATHY IN NIGERIA
We describe a case of human T-lymphotropic virus type I associated myelopathy in a 50-year old woman in Nigeria. The patient presented with progressive loss of tone to the two lower limbs and later inability to walk.
O. D. OLALEYE +4 more
doaj +1 more source
Testing problems in diagnosing human T-lymphotropic virus (HTLV) infection, mostly HTLV-II, have been documented in HIV/AIDS patients. Since December 1998, the Immunology Department of Instituto Adolfo Lutz (IAL) offers HTLV-I/II serology to Public ...
Fabrício Jacob +3 more
doaj +1 more source

